Roche Oncology Event
Basel, 19 June 2006
Roche’s Investor and Analyst Briefing
Roche Oncology Event
The Roche Oncology Event was held on 19 June 2006 near Zurich, Switzerland.
Programme and presentations:
| 11.00 | Setting new standards of cancer care PDF Bill Burns, CEO Division Roche Pharmaceuticals |
| 11.10 | Roche strategy to develop cancer medicines PDF Eduard E. Holdener, Head of Global Pharma Development |
| 11.25 | External speaker PDF Peter Harper, Consultant Physician and Medical Oncologist at Guy's St. Thomas Hospital, London, UK |
| 11.45 | Roche setting the standards of cancer care PDF
|
| 12.15 | Q&A |
| 12.25 | Lunch |
| 13.10 | Latest update on Roche Oncology portfolio |
| Herceptin: Bart Vanhauwere Lifecycle Leader PDF | |
| Tarceva: Don Maclean Lifecycle Leader PDF | |
| Xeloda: Jonathan Dickinson Lifecycle Leader PDF | |
| MabThera: David Loew Lifecycle Leader PDF | |
| Avastin: Stefan Frings Deputy Lifecycle Leader PDF | |
| 14.15 | Q&A |
| 14.25 | First workshop session: |
| Marketing a cancer drug PDF Pascal Soriot, Director of Pharma Business & Strategic Marketing | |
| Developing a cancer drug PDF Kapil Dhingra, Vice President, Medical Science | |
| Diagnostics and Biomarker development PDF Joachim Eberle, Head of R&D, Roche Centralized Diagnostics | |
| 15.10 | Repeated workshop session (please find presentation files above in 1st workshop session) |
| 16.00 | Roche early development pipeline in Oncology PDF Eduard E. Holdener, Head of Global Pharma Development |
| 16.15 | Bill Burns - Closing remarks |
| Venue: | Giardino Verde In der Rüti 2 8142 Uitikon Zürich / Switzerland Phone: +41-44-495-74-74 Fax: +41-44-495-74-70 www.giardinoverde.ch |